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Abstract
In AtT-20 cells ACTH secretion is regulated by both Ca2+ and G proteins. We previously
demonstrated that calnuc, an EF-hand Ca2+ binding protein which regulates Alzheimer's β-amyloid
precursor protein (APP) biogenesis, binds both Ca2+ as well as Gα subunits. Here we investigate
calnuc's role in G protein-mediated regulation of ACTH secretion in AtT-20 neuroendocrine
secretory cells stably overexpressing calnuc-GFP. Similar to endogenous calnuc, calnuc-GFP is
mainly found in the Golgi, on the plasma membrane (PM), and associated with regulated secretion
granules (RSG). By deconvolution immunofluorescence, calnuc-GFP partially colocalizes with Gαi1/
2 and Gαi3 at the PM and on RSG. Cytosolic calnuc(ΔSS)-CFP with the signal sequence deleted also
partially colocalizes with RSG and partially cosediments with Gαi1/2 in fractions enriched in RSG.
Overexpression of calnuc-GFP specifically increases the distribution of Gαi1/2 on the PM whereas
the distribution of Gβ subunits and synaptobrevin 2 (Vamp 2) is unchanged. Overexpression of
calnuc-GFP or cytosolic calnuc(ΔSS)-CFP enhances ACTH secretion two-fold triggered by
mastoparan or GTPγS but does not significantly affect glycosaminoglycan (GAG) chain secretion
along the constitutive pathway or basal secretion of ACTH. Calnuc's facilitating effects on ACTH
secretion are decreased after introducing anti-Gαi1/2, Gαi3, Gβ or calnuc IgG into permeabilized
cells but not when Gα12 or preimmune IgG is introduced. The results suggest that calnuc binds to
Gα subunits on the Golgi and on RSG and that overexpression of calnuc causes redistribution of
Gαi subunits to the PM and RSG, indicating that calnuc plays a role in dynamic distribution of only
Gα but not Gβ subunits. Thus calnuc may connect G protein signaling and calcium signaling during
regulated secretion.
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Calnuc (nucleobindin) [1,2], an EF-hand Ca2+ binding
protein, was previously reported to bind Ca2+ and several
Gα subunits in vivo [3,4]. Calnuc is unusual in that it is
found both within the Golgi lumen and in the cytoplasm
[3]. We previously demonstrated that the luminal pool of
calnuc constitutes of an agonist-releasable Ca2+ store in
the Golgi [5], and regulates Alzheimer's β-amyloid precur-
sor protein (APP) biogenesis [6], whereas cytoplasmic cal-
nuc binds several Gα subunits [3,7,8].
Transport along the regulated secretory pathway and exo-
cytosis of secretion granules involves vesicular trafficking,
fusion of secretory granules with the plasma membrane
(PM), followed by release of granule contents. Regulated
secretion is stimulated by Ca2+ [9] and heterotrimeric G
proteins, including several Gα and Gβγ subunits [10-12].
Among these, Gαi3 was found to facilitate histamine
release from mast cells [13], noradrenaline release from
adrenal chromaffin cells [14], and adrenocorticotropic
hormone (ACTH) secretion from AtT-20 cells [15]. The
recent discovery that corticotrophin releasing hormone
(CRH) and vasopressin (VP) regulate ACTH secretion via
binding to the Type 1 CRH receptor and the V1b receptor,
which are G protein coupled receptors (GPCRs), verifies
the regulation of ACTH secretion by G proteins [16].
Moreover, several G proteins have been found on intrac-
ellular membranes as well as on the PM. Gαi3 is associ-
ated with Golgi membranes as well as at the PM [17,18],
and Gαi1/2 is found on secretory vesicles [14,19,20].
We have previously reported that calnuc is associated with
regulated secretion granules (RSG) [21] and binds to Gαi3
in the Golgi [8]. In addition, we hypothesized that calnuc
might modulate regulated secretion by virtue of its ability
to bind Gαi3 and Ca2+. To obtain direct evidence for the
role of calnuc in the regulation of G protein mediated
ACTH secretion we overexpressed calnuc-GFP in AtT-20
cells. We report here that overexpressed calnuc-green fluo-
rescent protein (GFP) partially codistributes with Gαi1/2 as
well as Gαi3 on the cytoplasmic surface of regulated secre-
tory granules (RSG), facilitates ACTH secretion triggered by
the G protein activators GTPγS or mastoparan and causes
redistribution of Gαi subunits by increasing Gαi1/2 on the
PM and Gαi3 on RSG. Thus calnuc, the only protein dem-
onstrated to bind both Ca2+ and Gα subunits [3], appears
to play an important role in regulation of G protein and
Ca2+-related signaling events in endocrine cells.
Results
Distribution of Endogenous Calnuc in AtT-20 Cells and in 
Cells Stably Overexpressing Calnuc-GFP or Calnuc (ΔSS)-
CFP
We have previously reported [21] that most of the endog-
enous calnuc is concentrated in the Golgi region in AtT-20
cells (Fig. 1A) with some also associated with the PM and
immature secretory granules. Calnuc-GFP directly visual-
ized in live AtT-20 cells (Fig. 1B) or seen by deconvolution
analysis of immunostained fixed sections (Fig. 1E) is sim-
ilarly concentrated in the Golgi region, but it is also asso-
ciated with regulated secretion granules (RSG) which
contain ACTH located at the tips of the cell processes (Fig.
1D–F). In addition to its presence in the Golgi and RSG,
some calnuc-GFP is also found at the PM (Fig. 1B) [8].
Our previous morphological and biochemical data estab-
lished that calnuc is secreted by the constitutive-like path-
way, as it is packaged into immature secretory granules in
the Golgi, sorted out of RSG during their maturation, and
secreted by the constitutive pathway [21].
When calnuc(ΔSS)-CFP with the signal sequence deleted
which is located in the cytoplasm [8] is expressed and
viewed by live cell imaging, it is seen to be distributed
throughout the cytoplasm (Fig. 1C). However, when fixed
cells are permeabilized before fixation (to release
cytosolic calnuc), immunostained with an anti-GFP IgG,
and examined by immunofluorescence and deconvolu-
tion analysis, calnuc(ΔSS)-CFP is also seen to be associ-
ated with RSG based on colocalization with ACTH (Fig.
1G–I). The findings with this mutant suggest that some of
the cytosolic calnuc binds to the cytoplasmic surface of
RSG. Thus calnuc appears to be located both inside RSG
as well as bound to the cytoplasmic surface of RSG mem-
branes.
Distribution of Gαi Subunits in Parental (NT) AtT-20 Cells 
and Those Stably Expressing Calnuc-GFP and 
Calnuc(ΔSS)-CFP
Next we investigated the distribution of Gα subunits in
AtT-20 cells. In parental AtT-20 cells, Gαi3 is found on
both the PM and the Golgi (Fig. 2A) as previously
reported [21], and Gαi1/2 is associated mainly with RSG
located in both the cell bodies and tips of the AtT-20 cell
processes (Figs. 2C and 3A–C). In AtT-20 cells stably
expressing calnuc-GFP, more Gαi3 appears to be associ-
ated with RSG (Figs. 2B and 3D–F), and both Gαi1/2
(Figs. 2D and 3A–C) and Gαi3 (Fig 2B and 3D–F) are
observed on the PM as well as on RSG.
Calnuc-GFP partially colocalizes with Gαi3 in the Golgi
(Fig. 3G–I) and partially co-distributes with Gαi1/2 (Fig.
3J–L) and Gαi3 (Fig. 3G–I) on RSG and the PM. In cells
stably expressing cytosolic calnuc(ΔSS)-cyan fluorescent
protein (CFP), the majority of the Gαi1/2 and membrane
associated calnuc colocalize on RSG (Fig. 3M–O). Both
Gαi1/2 and calnuc(ΔSS)-CFP are concentrated on the
cytoplasmic surface of RSG and the PM. Thus, based on
deconvolution analysis of our immunofluorescence
results, it is evident that 1) both Gαi1/2 and Gαi3 are
found on RSG where they partially colocalize with ACTH,
and 2) in cells expressing calnuc-GFP the distribution of
Gαi subunits along the PM and RSG is enhanced.Page 2 of 16
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G Protein Subunits in Membrane vs Cytosolic Fractions 
from Parental and Stably Transfected AtT-20 Cells
To further check the distribution and expression of calnuc
and G proteins in AtT-20 cells we analyzed their distribu-
tion in membrane (100,000 × g pellet) vs cytosolic
(100,000 × g supernatant) fractions. Figure 4A shows that
endogenous calnuc (63 kD) and calnuc-GFP (91 kD) are
found in both cytosolic and membrane fractions. The
amount found in cytosolic fractions was greater for cal-
nuc-GFP (80%) than endogenous calnuc (50%). Most
(>90%) of the calnuc(ΔSS)-CFP (89 kD) was found in the
cytosolic fraction, but ~10% pelleted with membranes in
keeping with the immunofluorescence results demon-
strating its association with RSG. The distribution of proo-
piomelanocortin (POMC)-derived products including
POMC, POMC intermediate, glycosylated ACTH
(gACTH) and mature ACTH was also checked and was
similar in parental AtT-20 cells and those overexpressing
calnuc-GFP (Fig. 4B). Synaptobrevin 2 (Vamp 2) which
localizes on both RSG and synaptic vesicles was found
exclusively in membrane fractions (Fig. 4B). 80% of the
Gαi1/2, Gαi3 and Gβ subunits were associated with
membrane fractions in parental AtT-20 cells and 90% in
Characterization of AtT-20 cells stably overexpressing calnuc-GFP or Calnuc(ΔSS)-CFPFigure 1
Characterization of AtT-20 cells stably overexpressing calnuc-GFP or Calnuc(ΔSS)-CFP. (A). Immunofluores-
cence showing that most of the endogenous calnuc is found in the Golgi region (G) with some found on the PM (arrow) (B) 
Stably expressed calnuc-GFP in live AtT-20 cells is also concentrated in the Golgi with some found on the PM, but it is also 
associated with RSG stored at the tips of cell processes. (C) Stably expressed mutant calnuc(ΔSS)-CFP is distributed through-
out the cytoplasm in live AtT-20 cells. (D-F). Deconvolution analysis of immunofluorescence images demonstrates that calnuc-
GFP partially colocalizes with ACTH in RSG (yellow in F) at the tips of the cell processes (arrowhead in F) and in the Golgi 
region (G). (G-I). Deconvolution analysis of AtT-20 cells stably expressing calnuc(ΔSS)-CFP demonstrates that cytosolic calnuc 
is found on RSG and partially colocalizes with ACTH (yellow in I).). Bar = 10 μm.
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found in the calnuc-GFP cells. We conclude that overex-
pression of calnuc-GFP does not significantly change the
expression level or localization ratio (membrane vs
cytosolic fractions) of Gαi subunits, ACTH or its deriva-
tives.
Overexpression of Calnuc-GFP Does Not Affect 
Constitutive Secretion of GAG Chains or Basal Secretion 
of gACTH and Its Precursors in AtT-20 Cells
Next we examined the effects of overexpression of calnuc-
GFP on secretion of glycosaminoglycan (GAG) chains,
commonly used as a marker of constitutive secretion from
AtT-20 cells [22] and on basal secretion of ACTH and its
precursors. No change was detected in GAG secretion, as
similar amounts of GAG chains were secreted from both
parental AtT-20 cells and those expressing calnuc-GFP
over a period of 15 min to 2 h (Fig. 5A). The intracellular
and basal secreted metabolically labeled POMC, interme-
diate, glycosylated ACTH (gACTH) was also similar in
parental (NT) and in calnuc-GFP (CNG) cells after a 2 h
chase. However, certain increased secreted (Lane 2) and
intracellular mature ACTH (Lane 4) were observed follow-
ing overexpression of calnuc (Fig. 5B).
Overexpression of Calnuc-GFP Increases ACTH Secretion 
from AtT-20 Cells Stimulated by Mastoparan or GTPγS 
and the Effect Is G protein-dependent
To investigate if calnuc plays a role in regulated secretion
we used permeabilized, parental AtT-20 cells and those
overexpressing calnuc-GFP or calnuc(ΔSS)-CFP. Cells
were permeabilized with digitonin, and ACTH secretion
was triggered with the wasp venom peptide mastoparan
which mimics receptor activation of G proteins by bind-
ing to the C-terminus of Gαi and Gαq [23]. Mastoparan
has been used to study exocytosis in AtT-20 by others [15].
We found that when cells were stimulated with mas-
toparan, 30% of the total ACTH was secreted by parental
cells whereas the amount secreted by cells expressing cal-
nuc-GFP was ~60% of the total or double that found in
parental cells (Fig. 6A). The amount secreted by cells
expressing calnuc(ΔSS)-CFP was also increased (~55% of
total). ACTH secretion was similarly increased in calnuc-
GFP or calnuc(ΔSS)-CFP cells after stimulation with
GTPγS (another G protein activator), where 70–75% of
the total ACTH was secreted vs 40% in parental cells or
those overexpressing GFP alone (Fig. 6A). The result indi-
cates that calnuc enhances regulated secretion of ACTH
triggered by the G protein activators mastoparan and
GTPγS.
Next we investigated whether the effects of calnuc on
ACTH secretion is G protein dependent by introducing
affinity purified antibodies against Gαi, Gβ or calnuc into
the cytoplasm of calnuc-GFP cells. ACTH secretion trig-
gered by mastoparan from cells pre-treated with anti-cal-
nuc, anti-Gα1/2, anti-Gαi3 and anti-GβIgG decreased by
42%, 33%, 50%, and 42% respectively, compared to non-
treated AtT-20 cells or those treated with preimmune IgG
(Fig. 6B). No significant change in ACTH secretion was
seen from non-stimulated calnuc-GFP cells or those pre-
treated with either anti-Gα12 as a negative control or cal-
nuc preimmune IgG. Together the results obtained with
mastoparan treatment and antibody inhibition support
the conclusion that calnuc as well as G protein subunits
stimulate regulated secretion of ACTH in AtT-20 cells.
Calnuc Does Not Regulate G protein Activity
We next investigated if calnuc's effects on ACTH secretion
triggered by mastoparan and GTPγS are due to regulation
of G protein activity. Calnuc was previously demonstrated
by us to bind to the same region of the C-terminal α5-
helix on Gαi3 as mastoparan [7]. We therefore investi-
gated if purified, recombinant calnuc behaves similarly to
mastoparan (Fig. 7). Mastoparan was found to increase
GTPγS binding to Gαi3 over a 5 to 60 min period. 5 min
after the reaction was started, mastoparan increased
Redistribution of Gαi subunits after overexpressing calnuc-GFPFigure 2
Redistribution of Gαi subunits after overexpressing 
calnuc-GFP. Gαi3 is found on the PM (arrows) and on the 
Golgi (G) in parental AtT-20 cells (A) and in those expressing 
calnuc-GFP (B). Some Gαi3 is found on RSG in cells express-
ing calnuc-GFP (B). Gαi1/2 is found mainly on RSG (arrows) 
in the cell bodies and tips of the cell processes (arrowheads) 
in both parental (C) and calnuc-GFP cells (D). More Gαi1/2 
is observed on the PM (arrows) in cells overexpressing cal-
nuc-GFP (D) cells than in parental AtT-20 cells (D).). Bar = 
10 μm.
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Distribution of Gαi subunits in AtT-20 cells stably expressing calnuc-GFP or calnuc(ΔSS)-CFPFigure 3
Distribution of Gαi subunits in AtT-20 cells stably expressing calnuc-GFP or calnuc(ΔSS)-CFP. (A-F). Deconvo-
luting analysis of cells expressing calnuc-GFP which had been doubly stained for ACTH and endogenous Gαi1/2 or Gαi3. Both 
Gi subunits are associated with RSG containing ACTH (yellow in C and F). (G-L). Deconvolution analysis of cells expressing 
calnuc-GFP and doubly stained for GFP and either Gαi3 or Gαi1/2 showing that the Gi subunits are distributed on the PM 
(arrows) and partially colocalize with calnuc-GFP (yellow in I and L) which is distributed in an interrupted pattern on the PM. 
Calnuc-GFP also colocalizes with Gαi3 on the Golgi (G). (M-O). Similar deconvolution analysis of AtT-20 cells expressing cal-
nuc(ΔSS)-CFP showing that some of the Gαi1/2 colocalizes with cytosolic targeted calnuc(ΔSS)-CFP on RSG (yellow dots in O) 
and the PM (arrows). Bar = 10 μm.
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ilar to that described for Gαi1 [23]. However, in contrast
to mastoparan or AGS3 (Activator of G protein signaling
3) [24], no effect was observed when calnuc was added in
the same assay (Fig 7). This result indicates that although
it binds Gαi in vivo [8], it most likely does not regulate G
protein activity. In addition, calnuc was not found to pos-
sess GAP activity (data not shown). We conclude that
although calnuc binds Gα subunits, it most likely does
not act as a GDI, GEF or GAP for these G proteins.
Calnuc-GFP Localizes in Both Light and Heavy Membrane 
Fractions
Our findings that calnuc increases ACTH secretion and
anti-G protein antibodies partially block this effect, sug-
gests that calnuc's effects on ACTH secretion occur via G
proteins. Because our immunofluorescence results (Fig. 2)
suggested a shift in the distribution of Gα subunits occurs
following overexpression of calnuc-GFP, we analyzed the
effects of overexpressing calnuc on G protein distribution
by subcellular fractionation. Initially we used a sucrose
gradient centrifugation protocol [25] aimed at separating
Golgi and PM (light fractions) from ER and RSG (heavy
fractions). In keeping with the immunofluorescence
results, we found that the majority of the endogenous cal-
nuc (>90%) found in parental AtT-20 (NT) cells is con-
centrated in light fractions (9–12) containing Golgi and
PM (Fig. 8) where it cosediments with the Golgi marker α-
mannosidase II (Man II). Overexpressed calnuc-GFP is
also concentrated mostly in light fractions (>90%), but
some (<10%) is also found in heavy fractions (3–8) con-
taining ER and granules where it cosediments with cal-
nexin, an ER marker, and ACTH and synaptobrevin 2
(Vamp 2), markers for RSG. This is in keeping with our
finding that calnuc-GFP colocalizes with RSG. The distri-
bution in the gradient and level of expression of Vamp 2
and ACTH are not significantly changed following overex-
pression of calnuc-GFP. The results indicate that unlike
endogenous calnuc mainly localize in the Golgi, overex-
pressed calnuc localzed in both heavy (ER and granules)
and light (plasma membrane and Golgi) fraction. How-
ever, overexpression of calnuc doesn't change ACTH and
Vamp 2 distribution.
Overexpression of Calnuc Affects Distribution of Gαi 
Subunits
We next examined whether the distribution of G proteins
changes upon overexpression of calnuc-GFP using the
same sucrose gradient protocol. Figure 9 shows that in
parental AtT-20 cells (NT), the majority of the Gαi1/2
(70%) is in heavy fractions (3–8) containing ER and RSG,
and the majority of the endogenous Gαi3 (72%) sedi-
ments in the light fractions (10–12) containing Golgi and
PM. In cells overexpressing calnuc-GFP, the total Gαi1/2
in the heavy fractions is reduced to 55% with a corre-
Biochemical characterization of parental AtT-20 cells and th se overexpressing C lnuc-GFPF gur  4
Biochemical characterization of parental AtT-20 
cells and those overexpressing Calnuc-GFP. Postnu-
clear supernatants (PNS) prepared from parental AtT-20 
cells or those stably overexpressing calnuc-GFP or cal-
nuc(ΔSS)-CFP were analyzed by immunoblotting. (A) Endog-
enous calnuc (63 kD) is found in approximately equal 
amounts in the cytosolic (S) (100,000 × g supernatant) and 
membrane (P) (100,000 × g pellet) fractions. Calnuc-GFP (91 
kD) is present in both fractions but is more abundant (~80%) 
in the cystolic fraction. Most (79%) of the mutant cal-
nuc(ΔSS)-CFP (89 kD) is in the cytosolic (S) fraction. (B) The 
distribution of POMC, intermediate, glycosylated ACTH 
(gACTH) and mature ACTH is similar in parental cells (NT) 
cells and in cells overexpressing calnuc-GF (CNG). A small 
amount of ACTH is found in the cytosolic fraction of cells 
overexpressing calnuc-GFP, presumably due to leakage dur-
ing preparation of the fractions. Synaptobrevin 2 (Vamp 2), 
an integral membrane protein, is found exclusively in mem-
brane fractions. 90% of the Gβ subunits and 80% of the 
Gαi1/2 and Gαi3 are found in membrane fractions in paren-
tal (NT) cells. A faint band of slower mobility is seen in the 
case of Gβ subunits in the soluble fraction of CNG cells.
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Calnuc does not affect constitutive secretion of GAG chains or basal secretion of gACTH and its precursorsFigure 5
Calnuc does not affect constitutive secretion of GAG chains or basal secretion of gACTH and its precursors. 
(A) Overexpressed calnuc does not affect constitutive secretion of glycosaminoglycan (GAG) chains from either parental AtT-
20 cells (NT) or those stably transfected with calnuc-GFP over the time period indicated (15 min to 2 h). ~85% of the GAG 
chains were secreted from both cell types at 2 h. Results (mean ± SD) represent the average of values obtained in 3 separate 
experiments. Cells were pretreated with 0.5 mM xyloside and subsequently pulse-labeled with [35S]sulfate for 5 min. Secreted 
GAG chains were precipitated with cetylpyridinium chloride. Samples collected by vacuum filtration were counted by liquid 
scintillation. (B) Comparing to parental cells, in those overexpressing calnuc, no significant difference of gACTH and POMC + 
intermediate is observed both extracellularly (Lanes 1 and 2) and intracellularly (Lnaes 3 and 4). However, relatively increased 
secreted (Lane 2) and intracellular (Lane 4) mature ACTH are shown when calnuc is overexpressed. Med: medium; Cell: intra-
cellular.
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Gαi3 is found to have a broader distribution (fractions 3–
12) in heavier fractions in calnuc-GFP cells, which is con-
sistent with the localization of Gαi3 on RSG in these cells
(see Figs. 3D–F). Gβ subunits are broadly distributed
throughout the gradient in both heavy and light fractions,
and their distribution is unchanged following overexpres-
sion of calnuc-GFP. These findings indicate that overex-
pression of calnuc-GFP results in increased Gαi1/2 found
in light fractions containing Golgi and PM and a broader
distribution of Gαi3 in heavy fractions.
Overexpression of Calnuc-GFP Increases Distribution of 
Gαi1/2 on the PM in AtT-20 Cells
To further distinguish whether the increased Gαi1/2
found in light fractions is associated with Golgi mem-
branes or the PM, we used a sucrose gradient flotation
method [26] designed to separate light fractions (5–8)
enriched in PM from heavy fractions (1–3) containing
Golgi and ER. The % of the total Gαi1/2 in PM fractions
(fractions 5–8) increased from 38% to 63% following
overexpression of calnuc-GFP (Fig. 10). No striking
change in the distribution of Gαi3 in fractions 6–8 (95%
in calnuc-GFP cells vs. 90% in parental cells) was
observed except that a broader spread throughout the gra-
dient (fractions 1–8) was seen, similar to that of calnuc-
GFP. In parental cells, the Golgi marker (β-COP) and
Calnuc-GFP or Calnuc(ΔSS)-CFP increases ACTH secretion triggered by mastoparan or GT γS and the effect is G pro-ein-dependentFi ur  6
Calnuc-GFP or Calnuc(ΔSS)-CFP increases ACTH 
secretion triggered by mastoparan or GTPγS and the 
effect is G protein-dependent. (A) The amount of total 
ACTH secreted after stimulation with mastoparan increases 
from 30% in parental (NT) cells or those expressing GFP 
alone to 60% and 50% in AtT-20 cells overexpressing calnuc-
GFP and calnuc(ΔSS)-CFP (CNGΔSS), respetively. Similar 
effects are observed after stimulation with GTPγS where 70–
75% of the total ACTH is secreted in cells overexpressing 
calnuc-GFP (CNG) or calnuc(ΔSS)-CFP cells vs 40% in paren-
tal cells (NT) or those expressing GFP alone. Results (mean 
± SD) represent the average of values obtained in 3 separate 
experiments performed in triplicate. (B). Introduction of 
anti-calnuc or anti-G protein antibodies decreases ACTH 
secretion triggered by mastoparan. In control cells (no-treat-
ment) or those treated with preimmune or anti-Gα12 IgG, 
55–60% of the total ACTH was secreted. After pre-treat-
ment with anti-calnuc, anti-Gαi1/2, anti-Gαi3 and anti-
GβIgG, ACTH secretion triggered by mastoparan was 
decreased to 37%, 43%, 32% and 37%, respectively. Results 
(mean ± SD) represent the average of values obtained in two 
separate experiments performed in duplicate.
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Calnuc does not affect binding of GTPγS to Gαi3Figure 7
Calnuc does not affect binding of GTPγS to Gαi3. 
Addition of calnuc to Gαi3 has no effect on its rate of GDP 
exchange and binding of GTPγS, whereas mastoparan (used 
as a positive control) greatly enhances binding of GTPγS to 
Gαi3. Results (means ± SD) represent the average of values 
obtained in 3 separate experiments after subtraction of the 
blank (0.1% of the total radioactivity added). Mastoparan 
(100 μM) or His6-calnuc (1 μM) was incubated with 2 μM 
[35S]GTPγS. Reactions were started by adding 200 nM His6-
Gαi3 and incubated at 30°C for 0–60 min. 50 μl of the reac-
tion mixture were collected on nitrocellulose filters by vac-
uum filtration. Bound radioactivity was determined by liquid 
scintillation counting.
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Overexpressed calnuc-GFP is concentrated in light membrane fractions containing plasma membranes and Golgi membranesFigure 8
Overexpressed calnuc-GFP is concentrated in light membrane fractions containing plasma membranes and 
Golgi membranes. (A) Majority (90%) of the endogenous calnuc (NT) is in light fractions 10–12 containing Golgi and PM, 
with the remaining 10% found in heavy fractions (3–8). Calnuc-GFP is similarly concentrated in light fractions (75%), but some 
(25%) is also found in heavy fractions 3–8 containing ER and RSG, where it cosediments with synaptobrevin 2 (Vamp 2) and 
ACTH, a marker for RSG. No major change in the distribution of Vamp 2 and ACTH is observed following overexpression of 
calnuc-GFP. The ER marker calnexin and the Golgi marker α-mannosidase II (Man II) are found in heavy fractions (3–8) and 
light fractions (9–12), respectively. Overexpression of calnuc-GFP was not found to significantly change the distribution of 
ACTH and Vamp in the gradients. The percent of the total for a given protein in each quantified fraction was plotted in (B). 
The amount of each protein found in fractions 3–8 and 10–12 were pooled and plotted in the bar graph as the percent of total 
as shown in (C). Similar distribution change of indicated proteins was observed in 3 separate experiments depicted.
Vamp 2 (CNG)
1 2 3 4 5 6 7 8 9 10 11 12
Man II
Calnuc-GFP
Calnuc (NT)
Calnexin
Golgi, PMER, granules
Vamp 2 (NT)
ACTH (NT)
ACTH (CNG)
%
  o
f T
ot
a
l  
Pr
o
te
in
 (s
in
gl
e
 fr
a
ct
io
n
)
1
CNG
 Cells
%
 of
 T
otal P
rotein
 (p
ooled)
N
T
 Cells
0
20
Man II
Calnexin
0
20
40 Calnuc
Calnuc-GFP
1 2 3 4 5 6 7 8 9
10 11 12
12.5
25
0
Vamp 2 (CNG)
Vamp 2 (NT)
0
50
100
0
50
100
0
50
100
Bottom            Fraction Numbers          Top       Pooled
3-8 10-12
40
0
20
1 2 3 4 5 6 7 8 9 10 11 12
ACTH (CNG)
ACTH (NT)
40
A
B
C
Molecular Neurodegeneration 2009, 4:15 http://www.molecularneurodegeneration.com/content/4/1/15
Page 10 of 16
(page number not for citation purposes)
Redistribution of Gαi subunits in AtT-20 cells overexpressing calnuc-GFPFigure 9
Redistribution of Gαi subunits in AtT-20 cells overexpressing calnuc-GFP. In parental AtT-20 cells (NT), the major-
ity of the endogenous Gαi1/2 (70%) is found in heavy fractions (3–8) containing ER and secretory granules, whereas most of 
the endogenous Gαi3 (72%) is present in light fractions (10–12) containing Golgi and PM. In cells overexpressing calnuc-GFP 
(CNG) the % of the total Gαi1/2 found in heavy fractions is reduced (55%), that in light fractions is correspondingly increased 
(41%), and Gαi3 is more broadly distributed in fractions 3–12. No obvious change in the distribution of Gβ is observed follow-
ing calnuc-GFP overexpression. Similar distribution change of indicated proteins was observed in 3 separate experiments 
depicted. The quantitative analysis shown by bar graph which was calculate based on the dot curve in left panel represent the 
result from the same illustrated experiment as indicated above. The experimental protocol is the same as for Figure 6. "B" and 
"C" were calculated and plotted as in Figure 8A.
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in heavy fractions in keeping with its Golgi localization.
These results together with the immunofluorescence data
(Figs. 2C–D) support the conclusion that overexpression
of calnuc leads to a shift in the distribution of Gαi1/2
from RSG to the PM.
Discussion
Calnuc, the first protein identified that binds to both Ca2+
and heterotrimeric G proteins, was previously shown to be
localized both in the Golgi and in the cytoplasm [3]. Our
previous studies established that cytoplasmic calnuc specif-
ically interacts with several Gα subunits in vivo as shown by
both co-immunoprecipitation [3,4] and FRET analysis [8]
and that calnuc binds the C-terminal α5-helix region of
Gαi3 through its EF-hand Ca2+-binding region [7].
In this study we focused on defining the role of calnuc in
G protein dependent activation of ACTH secretion and
used GTPγS or mastoparan [15,23], a receptor mimetic
activator of Gi/o subunits, to trigger ACTH secretion. We
found that overexpression of calnuc increased nearly two-
fold ACTH secretion induced by mastoparan or GTPγS
compared to non-transfected cells. The fact that no differ-
ences were seen between calnuc-GFP (located both within
organelles along the secretory pathway and in the cyto-
plasm) and calnuc lacking its signal sequence (located
exclusively in the cytoplasm) together with our finding
that ACTH secretion is reduced when anti-calnuc antibod-
ies are introduced into permeabilized cells demonstrate
that it is the cytosolic pool that is responsible for calnuc's
effects on secretion. By immunofluorescence we found
that some of the calnuc(ΔSS)-CFP is associated with the
cytoplasmic side of RSG, indicating that this association
must occur by protein-protein interaction between calnuc
and a binding protein found on the cytoplasmic surface of
the RSG membrane.
Using antibodies against Gαi2 or Gαi3 we were able to
similarly impair ACTH secretion, but antibodies against
Gαi12 were without effect because mastoparan does not
activate Gα12. We found that mastoparan increases the
initial rate of GTPγS binding to Gαi3 four-fold compared
to Gαi3 alone or in the presence of calnuc. Mastoparan
does so by unwinding the α5 helix of Gαi1 which is
highly homologous to Gαi3 [23]. Although mastoparan
and calnuc have the same binding site in the α5 helix of
Gαi3, it appears that mastoparan and calnuc have differ-
ent mechanisms regarding regulation of ACTH secretion
because unlike mastoparan, calnuc can not regulate G
protein activity but affects G protein distribution.
We also investigated the effects of overexpression of calnuc-
GFP on G protein distribution. Our immunofluorescence
results demonstrate that in AtT-20 cells stably expressing
calnuc-GFP, calnuc-GFP partially colocalizes with Gαi1/2
as well as Gαi3 on the PM and Golgi membranes which is
similar to what we reported earlier in EcR-CHO cells over-
expressing calnuc and Gαi3-GFP [7] or in COS-7 cells over-
expressing calnuc-GFP and Gαi3-YFP visualized by FRET
[8]. Here we show (see Fig. 2C) that in non-transfected AtT-
20 cells Gαi1/2 is found mainly on secretory granules
(RSG) but not the PM which is consistent with reports by
others on chromaffin cells [14,19] and rat melanotrophs
[20]. However, in AtT-20 cells overexpressing calnuc the
distribution of Gαi1/2 is shifted in that more is found on
the PM and on RSG based on results obtained by both
immunofluorescence (Fig. 2D) and cell fractionation (Figs.
9, 10). When calnucΔSS-GFP lacking the calnuc signal
sequence is overexpressed in the cytoplasm, the majority of
Gαi1/2 was found to colocalize with cytosolic calnuc on
RSG. These results suggest that there is a dynamic distribu-
tion of Gαi between the cytoplasm, the PM, and mem-
branes of subcellular compartments such as the Golgi.
Based on our results we propose that cytosplasmic calnuc
may play a role in recruiting Gαi3 onto the granules and
Gαi1/2 onto the PM either from its cytosolic pool and/or
from its Golgi pool (Fig. 11). However, it is possible that
increasing the Ca2+ concentration in the Golgi by calnuc
overexpression [5] may also contribute to regulation of
membrane trafficking [25,27-29] which further results in
redistribution of G proteins.
Calnuc resembles several other proteins that are also
localized in two pools [30,31]. We established that calnuc
is distributed both in the Golgi lumen and in the cyto-
plasm in numerous cell lines [3,7]. Recently, NEFA
[32,33] a protein that has high homology to calnuc and
also has a signal sequence, has also been found both
within the Golgi lumen and in the cytoplasm [34]. Several
mechanisms have been proposed to explain the dual
localization of the same protein [30,31,35,36]. It has been
suggested that under some conditions the signal sequence
may be masked by binding proteins other than SRP
[35,36]. The detailed mechanism for generating two pools
of calnuc remains to be elucidated.
Regulated exocytosis has been extensively investigated to
date in AtT-20 and other cells [37-40]. It has become clear
that it requires multiple steps that need to be controlled in
time and space. Ca2+ and heterotrimeric G proteins have
been shown to affect exocytosis either separately or in syn-
ergy depending on the cell type. In AtT-20 cells exocytosis
is dependent on both Ca2+ and heterotrimeric G proteins
[12,41]. We found that calnuc binds both Ca2+ and heter-
otrimeric G proteins and is found on secretory vesicles
which places it in a strategic location to serve as a vesicle
bound controller of regulated secretion.
In summary, in this study we demonstrate that overex-
pression of calnuc, a Ca2+ and heterotrimeric G proteinPage 11 of 16
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Total Gαi1/2 associated with PM is increased following overexpression of calnuc-GFPFigure 10
Total Gαi1/2 associated with PM is increased following overexpression of calnuc-GFP. Light fractions enriched in 
PM were separated from heavy fractions containing Golgi and ER by sucrose gradient flotation. In parental cells (NT), the Golgi 
marker (β-COP) and most (84%) of the endogenous calnuc are concentrated in heavy fractions. In cells stably overexpressing 
calnuc-GFP (CNG), Calnuc-GFP is distributed across both light and heavy fractions, and the % of the total Gαi1/2 in PM-
enriched fractions (5–8) is increased from 38% to 63%. Most of the Gαi3 (75%) is found in PM fractions with the remaining 
(25%) associated with the Golgi in parental cells. Gαi3 has a broader distribution (fractions 1–8) in calnuc-GFP cells (CNG). 
Postnuclear supernatants in 1.3 M sucrose were overlayed with 1.2 M, 1.14 M, 0.99 M and 0.9 M sucrose, followed by centrifu-
gation at 170,000 × g for 15 h. Eight fractions were collected by centrifugation (100,000 × g for 1 h), and membrane pellets 
were analyzed by SDS-PAGE followed by immunoblotting. "B" and "C" were plotted as in Figure 6.
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Molecular Neurodegeneration 2009, 4:15 http://www.molecularneurodegeneration.com/content/4/1/15binding protein, results in redistribution of both Gαi1/2
on the PM and Gαi3 on RSG, indicating that calnuc plays
a role in dynamic distribution of only Gα but not Gβ sub-
units. Calnuc, which binds to Gα subunits on the vesicles,
modulates G protein activator triggered ACTH secretion
by redistributing Gαi1/2 and Gαi3.
Methods
Materials
Polyclonal rabbit IgG (F-5059) against recombinant full
length calnuc was generated and affinity purified as previ-
ously described [3]. Affinity purified rabbit anti-calnuc IgG
raised against the C-terminal 14 amino acids of rat/mouse
calnuc (EQPPVLPQLDSQHL) or human calnuc (LLERLPE-
VEVPQHL) was obtained from AVIVA System Biology Corp.
(San Diego, CA). Polyclonal antibodies against ACTH
(UV16) and monoclonal antibody (mAb) against synapto-
brevin 2 (Vamp 2) (69.1) were provided by Drs. J.D. Castle
(University of Virginia, Charlottesville, VA) and P. DeCamilli
(Yale University, New Haven, CT), respectively. Affinity puri-
fied IgG against Gαi1/2 (AS) and Gαi3 (EC) were gifts from
Drs. Teresa Jones and A. Spiegel (NIDDK). Polyclonal anti-
Gβ antibody (T-20) (Santa Cruz) which recognizes all Gβ
subunits and CFP cDNA were provided by Drs. P. Insel and
R. Tsien (University of California, San Diego), respectively.
MAbs against ACTH and GFP were purchased from Novacas-
tra Laboratories (Burlingame, CA) and Clontech Laborato-
ries (Palo Alto, CA), respectively. Highly cross-adsorbed
Alexa Fluor® 488 or 594-conjugated F(ab')2 fragments of goat
anti-mouse or goat anti-rabbit IgG (H+L) were from Molec-
ular Probes (Eugene, OR). Affinity purified goat anti-mouse
and goat anti-rabbit IgG (H+L) conjugated to horseradish
peroxidase were from Bio-Rad (Hercules, CA). Supersignal
chemiluminescent reagent was purchased from Pierce
(Rockford, IL). All chemicals were obtained from Sigma
except as indicated.
Cell Culture
AtT-20/D-16v pituitary cells were cultured in DME
medium (high glucose) supplemented with 10% (v/v)
horse serum, 2.5% (v/v) FCS (Life Technologies, Gaithers-
burg, MD), 100 U/ml penicillin G, and 100 μg/ml strep-
tomycin sulfate. Cells were used as 80% confluent
monolayers for transfection and subsequently selected
and maintained in the same culture medium containing
0.25 mg/ml G418 sulfate (Calbiochem, La Jolla, CA).
Establishment of AtT-20 Cells Stably Overexpressing 
Calnuc-GFP and Calnuc(ΔSS)-CFP
AtT-20 cells were transfected with GFP, calnuc-GFP or cal-
nuc(ΔSS)-CFP (lacking a signal sequence) cDNAs cloned in
the pcDNA3 vector, followed by G418 selection (0.75 mg/
ml) for 2–3 wk as previously described [5]. Cells were sub-
sequently sorted by FACS (Ex/Em: 488/530 ± 15) (FACS-
Vantage SE, Beckton Dickson, San Jose, CA) in the Flow
Cytometry Core Facility, UCSD Cancer Center. The highest
expressors (0.12% of the positive cells) were collected and
maintained in media containing 0.25 mg/ml G418. Selec-
tion by FACS sorting was repeated 3 times until 100% of
the cells were positive for calnuc-GFP or calnuc(ΔSS)-CFP.
Immunofluorescence and deconvloting analysis
Fluorescence images were collected from live AtT-20 cells
stably overexpressing calnuc-GFP, calnuc(ΔSS)-CFP or
GFP alone using a Zeiss Axiophot equipped with a FITC-
filter (Ex/Em: 485/510).
For immunofluorescence, cells were fixed in 2% parafor-
maldehyde in phosphate buffer and permeabilized as
Diagram of dynamic distribution of calnucFigure 11
Diagram of dynamic distribution of calnuc. There are 
two pools for caluc: cytosolic and the Golgi membrane asso-
ciated. Cytosolic calnuc interacts with Gαi subunits on the 
Golgi and vesicles budded from the Golgi, whereas luminal 
calnuc retains in the Golgi lumen for several hours, followed 
by secretion along the constitutive-like pathway. Calnuc 
binding the Golgi lumen is subjected to post-translational 
modification, and as the major calcium binding protein, plays 
a key role in constitution of a calcium pool in the Golgi. 
Cytosolic calnuc involves distribution of Gαi subunits via 
binding to them, and further participates regulation of G pro-
tein related intracellular pathways.
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0.1 μg polyclonal rabbit anti-calnuc, anti-ACTH, anti-
Gαi1/2(AS), and anti-Gαi3(EC), or anti-GFP mAb at
room temperature for 1 h, followed by incubation with
Alexa Fluor 488 or 594-conjugated anti-rabbit or anti-
mouse F(ab')2. Specimens were examined with a Zeiss
Axiophot microscope equipped for epifluorescence.
For deconvolution analysis of immunofluorescence
results, images were collected with an Applied Precision
DeltaVision imaging system (Issaquah, WA) coupled to a
Zeiss S100 fluorescence microscope (Carl Zeiss; Thorn-
wood, NY). Cross-sectional images of cells were obtained
with 150-nm step width to optimize reconstruction of the
center plane image. Deconvolution was done on a Silicon
Graphics Octane® visual workstation (SGI, Mountain
View, CA) equipped with Delta Vision reconstruction soft-
ware.
Assessment of Constitutive Secretion of 
Glycosaminoglycans (GAG) from AtT-20 Cells
Non-transfected AtT-20 cells or those transfected with cal-
nuc-GFP were pretreated with 0.5 mM xyloside at 37°C
for 30 min and subsequently pulse-labeled with [35S] sul-
fate (150 μCi/ml) (ICN Biomedicals) for 5 min as
described [22]. Labeled GAG chains secreted into the
medium at selected intervals from 15 min to 2 h were pre-
cipitated with cetylpyridinium chloride (CPC). Samples
were collected by vacuum filtration and counted by liquid
scintillation as previously described [22].
Immunoprecipitation of Metabolically Labeled ACTH and 
its Precursors
Parental AtT-20 cells or cells stably expressing calnuc-GFP
were pulse-labeled [42] with [35S]Met (0.5 mCi/ml)
(NEN® Life Science Products, Boston, MA) for 20 min at
37°C and subsequently chased in unlabeled DMEM for 2
h. ACTH released into the medium was immunoprecipi-
tated with anti-ACTH IgG and protein A beads (Cytelligen
Corp., San Diego, CA), followed by separation on 10–
20% Tris-Tricine gels (Bio-Rad) and autoradiography with
Kodak film [21].
ACTH Release from Permeabilized AtT-20 Cells
The permeabilization protocol used followed that
described previously by others [13]. In brief, stably trans-
fected or non-transfected AtT-20 cells were plated on tis-
sue culture plates (5 × 104/well) for 48 h, and
subsequently rinsed with 0.1% BSA in DMEM, followed
by permeabilization buffer (20 mM digitonin, 137 mM
NaCl, 2.7 mM KCl, 5.6 mM glucose, 1 mg/ml BSA, 20 mM
Hepes, pH 7.2), plus either 10 μM mastoparan (Neosys-
tem Laboratoire, Strasbourg, France) or 100 μM GTPγS
(Roche Molecular Biochemicals, Indianapolis, IN) at
37°C for 15 min [13,15,43]. To introduce antibodies into
cells, affinity purified anti-calnuc (F-5059), anti-Gαi1/2
(AS), anti-Gαi3 (EC) or anti-GβIgG (30 μg/ml) were
added and incubated with cells in permeabilization buffer
at 37°C for 10 min according to a published protocol
[44], followed by addition of 10 μM mastoparan for 15
min. Media were collected, and cells were lysed in 0.5%
Triton X-100 at 4°C for 30 min, followed by centrifuga-
tion (14,000 × g for 5 min). ACTH in supernatants of both
the medium and cell lysate were assessed by enzyme-
linked immunosorbent assay (ELISA) using ACTH (Rat)
EIAH kits (Peninsula Laboratories, San Carlos, CA) with a
Vmax Kinetic Microplate Reader (λ = 450 nm) (Molecular
Devices, Sunnyvale, CA). ACTH secretion was plotted as
percent of total ACTH (secreted ACTH in supernatants vs
secreted + intracellular ACTH). The results from each
experiment were subjected to statistic analysis, and the
final plotted results (mean ± SD) represent the average of
values obtained in indicated separate experiments per-
formed in either duplicate or triplicate as shown in figure
legend.
GTPγS Binding Assay
Purified recombinant His6-Gαi3 [45] and His6-calnuc [5]
were prepared as described previously and GTPγS binding
was assessed as described by others [23]. Mastoparan (100
μM) or His6-calnuc (1 μM) was incubated with 2 μM
[35S]GTPγS (6000 cpm/pmol, NEN® Life Science Products)
[42] in the reaction buffer containing 10% glycerol, 1 mM
DTT, 1 mM EDTA, 0.1 mM MgCl2, and 50 mM Hepes, pH
8.0. Reactions were started by addition of 200 nM His6-
Gαi3 and incubated at 30°C for 5–60 min. At each time
point, 50 μl of the reaction mixture were collected, diluted
with ice-cold dilution buffer (160 mM NaCl, 0.2 mM
GTP, 1 mM EDTA, and 20 mM Hepes, pH 8.0). Samples
were collected on nitrocellulose filters by vacuum filtra-
tion. Filters were washed with ice cold washing buffer (25
mM MgCl2, 100 mM NaCl, and 25 mM Tris, pH 8.0).
Bound radioactivity was determined by liquid scintilla-
tion counting. Total bound radioactivity never exceeded
2% of the total radioactivity.
Subcellular Fractionation
Membrane (100,000 g pellets) and cytosolic fractions
(100,000 g supernatants) were prepared by centrifugation
of postnuclear supernatants from AtT-20 cells and ana-
lyzed by immunoblotting and ECL [3].
Light membranes containing PM and Golgi membranes
were separated from heavy fractions containing ER and
granules by centrifugation on discontinuous sucrose gra-
dients using protocols similar to those previously pub-
lished with minor modifications [3,5]. Briefly,
postnuclear supernatants (PNS) prepared from AtT-20
cells were loaded on the top of sucrose step gradient con-
taining 0.2, 0.4, 0.6, 1.0, 1.4, and 1.8 M in 1 mM Tris-HCl,Page 14 of 16
(page number not for citation purposes)
Molecular Neurodegeneration 2009, 4:15 http://www.molecularneurodegeneration.com/content/4/1/15pH 7.5, and centrifuged at 55,000 × g (SW60Ti rotor) for
2 h at 4°C. After centrifugation, 12 fractions were col-
lected from the bottom, followed by centrifugation at
100,000 × g for 1 h. The resultant pellets were solubilized
in Laemmli sample buffer and the solubilized proteins
were separated on 10% Tris-Glycine or 10–20% Tris-Tri-
cine gels (Bio-Rad) and analyzed by immunoblotting.
To separate PM from Golgi membranes sucrose gradient
flotation [26] was applied as previously described [5] with
minor modifications. In brief, postnuclear supernatants
from AtT-20 cells were resuspended in 1.0 ml 1.3 M
sucrose, followed by overlay with 0.5 ml of 1.2 M, 1.5 ml
of 1.14 M, 0.5 ml of 0.99 M and 0.9 M sucrose, followed
by centrifugation at 170,000 × g (SW60Ti rotor) for 15 h
at 4°C. Eight fractions were collected by centrifugation
(100,000 × g for 1 h), and membrane pellets were ana-
lyzed by SDS-PAGE followed by immunoblotting. Quan-
tification of each band was performed by densitometry
using Scan Analysis software (Biosoft, Cambridge, UK).
Fraction density was determined using a digital refractom-
eter (ABBE Mark II) (Cambridge Instruments, Buffalo,
NY) as described [26].
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